202 related articles for article (PubMed ID: 19444444)
1. Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged.
Tang YC; Thoman M; Linton PJ; Deisseroth A
Cancer Immunol Immunother; 2009 Dec; 58(12):1949-57. PubMed ID: 19444444
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines.
Ceglia V; Zurawski S; Montes M; Kroll M; Bouteau A; Wang Z; Ellis J; Igyártó BZ; Lévy Y; Zurawski G
Front Immunol; 2021; 12():786144. PubMed ID: 35095862
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Scavenger Receptor Cysteine-Rich Domain Binding to Bacteria.
Telfer JC; Hsu H; Tyner MD; Le Page L
Methods Mol Biol; 2022; 2421():141-150. PubMed ID: 34870817
[TBL] [Abstract][Full Text] [Related]
4. The role of CD40 ligand in costimulation and T-cell activation.
Grewal IS; Flavell RA
Immunol Rev; 1996 Oct; 153():85-106. PubMed ID: 9010720
[TBL] [Abstract][Full Text] [Related]
5. Reduction of circulating regulatory T cells by intravenous high-dose interferon alfa-2b treatment in melanoma patients.
Mozzillo N; Ascierto P
Clin Exp Metastasis; 2012 Oct; 29(7):801-5. PubMed ID: 22752507
[TBL] [Abstract][Full Text] [Related]
6. Linkage of CD40L to a self-tumor antigen enhances the antitumor immune responses of dendritic cell-based treatment.
Chen HW; Huang HI; Lee YP; Chen LL; Liu HK; Cheng ML; Tsai JP; Tao MH; Ting CC
Cancer Immunol Immunother; 2002 Aug; 51(6):341-8. PubMed ID: 12111122
[TBL] [Abstract][Full Text] [Related]
7. Direct T cell activation via CD40 ligand generates high avidity CD8+ T cells capable of breaking immunological tolerance for the control of tumors.
Soong RS; Song L; Trieu J; Lee SY; He L; Tsai YC; Wu TC; Hung CF
PLoS One; 2014; 9(3):e93162. PubMed ID: 24664420
[TBL] [Abstract][Full Text] [Related]
8. Antiviral therapy reduces viral burden but does not prevent thymic involution in young cats infected with feline immunodeficiency virus.
Hayes KA; Phipps AJ; Francke S; Mathes LE
Antimicrob Agents Chemother; 2000 Sep; 44(9):2399-405. PubMed ID: 10952586
[TBL] [Abstract][Full Text] [Related]
9. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
10. Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine.
Cusi MG; Del Vecchio MT; Terrosi C; Savellini GG; Di Genova G; La Placa M; Fallarino F; Moser C; Cardone C; Giorgi G; Francini G; Correale P
J Immunol; 2005 Jun; 174(11):7210-6. PubMed ID: 15905566
[TBL] [Abstract][Full Text] [Related]
11. Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo.
Sin JI; Kim JJ; Zhang D; Weiner DB
Hum Gene Ther; 2001 Jun; 12(9):1091-102. PubMed ID: 11399230
[TBL] [Abstract][Full Text] [Related]
12. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
Gao D; Li J; Orosz CG; Bumgardner GL
Hepatology; 2000 Nov; 32(5):1018-28. PubMed ID: 11050052
[TBL] [Abstract][Full Text] [Related]
13. The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.
Powell AM; Luo Z; Martin L; Wan Z; Ma L; Liao G; Song Y; Li X; Michael Kilby J; Huang L; Jiang W
Vaccine; 2017 Feb; 35(5):831-841. PubMed ID: 28017428
[TBL] [Abstract][Full Text] [Related]
14. Preformed CD40 ligand exists in secretory lysosomes in effector and memory CD4+ T cells and is quickly expressed on the cell surface in an antigen-specific manner.
Koguchi Y; Thauland TJ; Slifka MK; Parker DC
Blood; 2007 Oct; 110(7):2520-7. PubMed ID: 17595332
[TBL] [Abstract][Full Text] [Related]
15. Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodies.
Medina-Echeverz J; Hinterberger M; Testori M; Geiger M; Giessel R; Bathke B; Kassub R; Gräbnitz F; Fiore G; Wennier ST; Chaplin P; Suter M; Hochrein H; Lauterbach H
Nat Commun; 2019 Nov; 10(1):5041. PubMed ID: 31695037
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD40L by the ALVAC-Simian Immunodeficiency Virus Vector Abrogates T Cell Responses in Macaques.
Silva de Castro I; Gordon SN; Liu J; Bissa M; McKinnon K; Trinh HV; Doster MN; Schifanella L; Liyanage NP; Cao J; Cheng O; Foulds K; Roederer M; Koup RA; Shen X; Tomaras GD; Venzon DJ; Forthal DN; Fouts T; Montefiori DC; Tartaglia J; Rao M; Ostrowski M; Franchini G; Vaccari M
J Virol; 2020 Feb; 94(6):. PubMed ID: 31896599
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of CD40L with CD70 or OX40L increases B-cell viability and antitumor efficacy.
Shin CA; Cho HW; Shin AR; Sohn HJ; Cho HI; Kim TG
Oncotarget; 2016 Jul; 7(29):46173-46186. PubMed ID: 27323820
[TBL] [Abstract][Full Text] [Related]
18. Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon hepatitis B vaccination.
Elias G; Meysman P; Bartholomeus E; De Neuter N; Keersmaekers N; Suls A; Jansens H; Souquette A; De Reu H; Emonds MP; Smits E; Lion E; Thomas PG; Mortier G; Van Damme P; Beutels P; Laukens K; Van Tendeloo V; Ogunjimi B
Elife; 2022 Jan; 11():. PubMed ID: 35074048
[TBL] [Abstract][Full Text] [Related]
19. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ
Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the CD40/CD40L role in the sustenance of alloreactive antibody production.
Shoker AS; Lun ZR; Choudry R; Saxena A
Transpl Immunol; 2001 Feb; 8(4):219-28. PubMed ID: 11316064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]